Plain-English translation of NCT06457906 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing two different ways to treat brain tumors that have spread from small-cell lung cancer. One approach uses targeted radiation therapy that focuses high doses directly on the tumors, while the other uses whole-brain radiation that treats the entire brain while protecting the memory center. The trial will help doctors understand which approach works better and causes fewer side effects for patients with 10 or fewer brain tumors.
Small-cell lung cancer often spreads to the brain early and aggressively, and brain tumors can seriously affect quality of life. Doctors are uncertain whether treating only the visible tumors with focused radiation is better than treating the whole brain, especially since whole-brain radiation can affect memory and thinking. This trial aims to find the safest and most effective approach.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either targeted radiation directly to your brain tumors or whole-brain radiation that spares your memory center. You will have detailed brain imaging scans before treatment, receive your assigned radiation therapy, and then return for follow-up visits and memory and thinking assessments over at least 6 months to see how well the treatment works and monitor for side effects.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China